References
- Hart A, Lentine KL, Smith JM, et al. OPTN/SRTR 2019 annual data report: kidney. Am J Transplant. 2021;21(Suppl 2):1–8.
- Tanabe T. The value of long-term protocol biopsies after kidney transplantation. Nephrology. 2014;19(Suppl 3):2–5.
- Nankivell BJ, Borrows RJ, Fung CL, et al. The natural history of chronic allograft nephropathy. N Engl J Med. 2003;349(24):2326–2333.
- Stegall MD, Cornell LD, Park WD, et al. Renal allograft histology at 10 years after transplantation in the tacrolimus era: evidence of pervasive chronic injury. Am J Transplant. 2018;18(1):180–188.
- Snanoudj R, Royal V, Elie C, et al. Specificity of histological markers of long-term CNI nephrotoxicity in kidney-transplant recipients under low-dose cyclosporine therapy. Am J Transplant. 2011;11(12):2635–2646.
- Loupy A, Haas M, Solez K, et al. The banff 2015 kidney meeting report: current challenges in rejection classification and prospects for adopting molecular pathology. Am J Transplant. 2017;17(1):28–41.
- Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982–992.
- Haas M, Sis B, Racusen LC, et al. Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant. 2014;14(2):272–283.
- Arai T, Oguchi H, Shinoda K, et al. Clinicopathological analysis of acute/active antibody-mediated rejection in renal allografts according to the banff 2013 classification. Nephron. 2020;144(Suppl 1):18–27.
- Sofue T, Suzuki H, Ueda N, et al. Post-transplant immunoglobulin a deposition and nephropathy in allografts. Nephrology. 2018;23(Suppl 2):4–9.
- Tervaert TW, Mooyaart AL, Amann K, et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21(4):556–563.
- Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int. 1999;55(2):713–723.
- Maryniak RK, First MR, Weiss MA. Transplant glomerulopathy: evolution of morphologically distinct changes. Kidney Int. 1985;27(5):799–806.
- Wavamunno MD, O’Connell PJ, Vitalone M, et al. Transplant glomerulopathy: ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies. Am J Transplant. 2007;7(12):2757–2768.
- Zhang Q, Rudolph B, Choi M, et al. The relationship between proteinuria and allograft survival in patients with transplant glomerulopathy: a retrospective single-center cohort study. Transpl Int. 2021;34(2):259–271.
- Nankivell BJ, PʼNg CH, OʼConnell PJ, et al. Calcineurin inhibitor nephrotoxicity through the lens of longitudinal histology: comparison of cyclosporine and tacrolimus eras. Transplantation. 2016;100(8):1723–1731.
- Morozumi K, Takeda A, Uchida K, et al. Cyclosporine nephrotoxicity: how does it affect renal allograft function and transplant morphology? Transplant Proc. 2004;36(2 Suppl):251s–256s.
- Floege J, Alpers CE, Burns MW, et al. Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab Invest. 1992;66(4):485–497.
- Haas M, Mirocha J. Early ultrastructural changes in renal allografts: correlation with antibody-mediated rejection and transplant glomerulopathy. Am J Transplant. 2011;11(10):2123–2131.